Ticker Details
Johnson & Johnson Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of products in the health care field within its Consumer, Pharmaceutical and Medical Devices segments.
IPO Date:	January 2, 1990
Sector:	Healthcare
Industry:	Pharma
Market Cap:	$581.22B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.70 | 0.65%
Avg Daily Range (30 D):	$1.76 | 0.73%
Avg Daily Range (90 D):	$1.73 | 0.77%

Institutional Daily Volume
Avg Daily Volume:	7.94M
Avg Daily Volume (30 D):	5.25M
Avg Daily Volume (90 D):	5.97M

Trade Size
Avg Trade Size (Sh.):	135
Avg Trade Size (Sh.) (30 D):	34
Avg Trade Size (Sh.) (90 D):	38

Institutional Trades
Total Institutional Trades:	161,034
Avg Institutional Trade:	$8.55M
Avg Institutional Trade (30 D):	$36.88M
Avg Institutional Trade (90 D):	$33.99M
Avg Institutional Trade Volume:	.08M
Avg Institutional Trades (Per Day):	28

Market Closing Trades
Avg Closing Trade:	$124.28M
Avg Closing Trade (30 D):	$415.66M
Avg Closing Trade (90 D):	$380.11M
Avg Closing Volume:	942.19K

News

Apr 10, 2026 @ 8:43 AM Crohn's Disease Eight-Market Drug Forecast and Mar... Source: Researchandmarkets.Com

Apr 10, 2026 @ 12:15 AM Could Buying This Dividend Pharma Stock Today Set ... Source: Reuben Gregg Brewer

Apr 7, 2026 @ 7:18 PM Martin Capital Dumps $4.5 Million in Robert Half S... Source: Andy Gould

Apr 7, 2026 @ 4:17 PM Microsoft Is Now The Biggest Deadweight On S&P 500... Source: Erica Kollmann

Apr 6, 2026 @ 5:20 PM Trump Imposes 100% Drug Tariffs: 5 Pharma Stocks T... Source: Jaachi Mbachu, Aci

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$11.13	$2.12	$11.13
Diluted EPS	$11.03	$2.09	$11.03
Revenue	$94.19B	$24.56B	$94.19B
Gross Profit	$63.94B	$16.6B	$63.94B
Net Income / Loss	$26.8B	$5.12B	$26.8B
Operating Income / Loss	$32.58B	$4.97B	$32.58B
Cost of Revenue	$30.26B	$7.97B	$30.26B
Net Cash Flow	$-4396M	$1.48B	$-4396M
PE Ratio	21.66

Splits
Jun 13, 2001	2:1